GET DAILY SIGNALSJRVR Stock: Can James River Group Holdings Deliver +25% Upside to $4.72?
Key Takeaways
- The central $4.72 stock price target is the arithmetic mean of three current analyst price targets, which range from approximately $4.45 to $5.00.
- At a recent price near $3.77, reaching $4.72 would require a gain of about 25%, a substantial but not extreme move.
- All three analysts carry a Hold or Neutral-equivalent rating, and the stock has faced a wave of downgrades since late 2025.
- JRVR trades at a low valuation, near 0.33 times book value and a single-digit P/E (price-to-earnings) ratio, offering a potential margin of safety.
- Profitability is the key obstacle: the consolidated combined ratio has run above 100%, meaning underwriting has not yet been consistently profitable.
- The stock sits near its 52-week low of $3.36, well below its 52-week high of $7.20, leaving meaningful recovery potential but also visible downside risk.
- For deeper coverage of this company, explore its Major News, Today's Price Move, Forecast, and Earnings pages.
- Readers seeking AI-driven market signals can also explore Trending AI Robots for automated trading insights.
What the Analyst Consensus Looks Like
The $4.72 average analyst price target reflects three active estimates gathered by S&P Global, with a low of about $4.45 and a high of $5.00. Recent adjustments highlight the cautious stance. In August 2026, UBS trimmed its target to $4.45 from $4.75 while maintaining a Hold, and Truist Financial lowered its target to $5.00 from $6.00, also keeping a Hold. There are no Buy ratings on the stock.
That neutrality follows a series of downgrades: UBS moved from Buy to Neutral in May 2026, Citizens JMP from Outperform to Market Perform in May 2026, and Compass Point from Buy to Neutral in December 2025. The consistent thread is skepticism about how quickly underwriting profitability can normalize, even as analysts acknowledge the shares look inexpensive on book value. The $4.45–$5.00 range is narrow, reflecting a consensus that any upside depends more on execution than on multiple expansion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Where JRVR Stands in the Market Today
JRVR last closed near $3.77, just above its 52-week low of $3.36 and roughly 48% below its 52-week high of $7.20. Reaching the $4.72 target implies upside of about 25%, which qualifies as a substantial move. The shares trade near 0.33 times book value and a P/E ratio in the single digits, so the market is pricing in continued earnings pressure rather than anticipating a quick recovery.
The path toward the target would most likely require the consolidated combined ratio to fall sustainably below 100%, meaning premium revenue begins exceeding claims and expenses. The E&S segment has historically shown stronger underwriting results than the consolidated figure, and any improvement there, alongside favorable reserve development and steadier investment income, would support a re-rating toward book value and beyond.
Factors That Could Help JRVR Reach the Target
- The E&S lines business operates in a niche market with pricing power, and specialty insurance demand has remained firm in recent periods.
- The stock's low price-to-book multiple provides a valuation floor argument; closing even part of the discount to book value would imply meaningful upside.
- A return to an underwriting profit, combined with the small dividend and improving earnings per share, could rebuild investor confidence.
- As a micro-cap with limited analyst coverage, any positive earnings surprise or improved guidance could prompt sharp target revisions higher.
Risks That Could Keep the Target Out of Reach
- A consolidated combined ratio above 100% indicates the company is paying out more in claims and expenses than it collects in premiums.
- The company missed earnings expectations in its most recent quarter, and shares fell sharply after that release, underscoring execution risk.
- The string of analyst downgrades and target cuts reflects limited conviction that profitability will recover quickly.
- Small-cap insurance names carry reserve risk, and adverse loss development or softening pricing could pressure book value and the stock.
Key Technical Levels to Watch
The 52-week low of $3.36 is the most important nearby support level, with the shares currently trading only modestly above it. On the upside, the $4.00 level acts as a psychological barrier, while the $4.45–$5.00 analyst target band roughly coincides with a resistance zone that would need to be cleared for a durable advance. The $7.20 prior high marks the far upper boundary of the long-term range. From what I see, monitoring these levels alongside broader market moves will be useful.
Time Horizon and Upcoming Catalysts
Analyst price targets generally reflect a research horizon of about 12 months, though individual timelines can differ. The next key event is the company's third-quarter earnings report, scheduled for November 9, 2026, with consensus expectations around $0.17 in EPS on roughly $134.8 million in revenue. Investors should watch the combined ratio, book value per share, reserve development, any guidance changes, and whether analyst ratings begin to stabilize or shift more positive. I’m watching this closely as the report approaches.
Exploring Tickeron AI Tools for Additional Context
In my view, adding systematic signals to fundamental work can sharpen decision-making. Tickeron’s AI Daily Buy/Sell Signals provide a practical way to track shifting conditions across thousands of names without constant manual effort. The platform scans for Buy, Sell, or Hold ideas based on technical and market data, which I find helpful when reviewing names like JRVR alongside earnings and valuation metrics. This approach has complemented my review process in several cases.
Final Assessment
The $4.72 central target, derived from three analyst estimates ranging from $4.45 to $5.00, represents roughly 25% upside from a price near $3.77. The bull case rests on a discounted valuation, a strong E&S franchise, and the possibility that underwriting profitability finally normalizes. The bear case centers on a combined ratio above 100%, recent earnings misses, and a steady drumbeat of downgrades. With the stock near its 52-week low, reaching $4.72 is plausible only if execution improves measurably; the next earnings report and any change in analyst sentiment will be the clearest near-term signals of whether that path is opening.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
JRVR's RSI Indicator slumps into oversold zone
The RSI Indicator for JRVR moved into overbought territory on November 10, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for JRVR crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where JRVR advanced for three days, in 180 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
JRVR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 81 of 128 cases where JRVR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JRVR as a result. In 80 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for JRVR turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 43 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
JRVR moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JRVR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JRVR's P/B Ratio (0.344) is slightly lower than the industry average of (0.987). P/E Ratio (7.939) is within average values for comparable stocks, (11.360). Projected Growth (PEG Ratio) (0.600) is also within normal values, averaging (0.944). Dividend Yield (0.010) settles around the average of (0.486) among similar stocks. JRVR's P/S Ratio (0.354) is slightly lower than the industry average of (2.529).
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. JRVR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JRVR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a insurance company
Industry SpecialtyInsurance
Advertisement